Europe Biotechnology Market Summary, Competitive Analysis and Forecast to 2028

February 2024 | 49 pages | ID: E6DFC0ED1A59EN
MarketLine

Abstracts

Europe Biotechnology Market Summary, Competitive Analysis and Forecast to 2028

Summary

Biotechnology in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

• The biotechnology market encompasses a broad range of technologies, products, and services that utilize biological systems, organisms, or derivatives to develop or modify processes or products for specific applications.
• The European biotechnology market recorded revenues of $261.9 billion in 2023, representing a compound annual growth rate (CAGR) of 8% between 2018 and 2023.
• The medical/healthcare segment accounted for the market's largest proportion in 2023, with total revenues of $184 billion, equivalent to 70.3% of the market's overall value.
• The European biotechnology market is experiencing growth due to innovation and the potential for significant therapeutic developments. Germany's biotechnology market is focusing on research and development, with numerous businesses investing in this field. For instance, in April 2023, Boehringer Ingelheim opened its new Biologicals Development Centre in Biberach a der RiЯ, Germany, with R&D financing totaling EUR350 million ($413.9 million), marking the company's largest single investment in Germany to date.

Scope

• Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Europe
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Europe
• Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the Europe biotechnology market with five year forecasts by both value and volume

Reasons to Buy

• What was the size of the Europe biotechnology market by value in 2023?
• What will be the size of the Europe biotechnology market in 2028?
• What factors are affecting the strength of competition in the Europe biotechnology market?
• How has the market performed over the last five years?
• What are the main segments that make up Europe's biotechnology market?

Contents

1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape

2 MARKET OVERVIEW

2.1. Market definition
2.2. Market analysis

3 MARKET DATA

3.1. Market value

4 MARKET SEGMENTATION

4.1. Category segmentation
4.2. Geography segmentation

5 MARKET OUTLOOK

5.1. Market value forecast

6 FIVE FORCES ANALYSIS

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 COMPETITIVE LANDSCAPE

7.1. Who are the leading players?
7.2. What strategies do the leading players follow?
7.3. What is the rationale behind recent M&A activity?

8 COMPANY PROFILES

8.1. Novartis AG
8.2. Bayer AG
8.3. AstraZeneca PLC
8.4. BioNTech SE

9 MACROECONOMIC INDICATORS

9.1. Country data

10 APPENDIX

10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List Of Tables

LIST OF TABLES

Table 1: Europe biotechnology industry value: $ million, 2018-23
Table 2: Europe biotechnology industry category segmentation: % share, by value, 2018-2023
Table 3: Europe biotechnology industry category segmentation: $ million, 2018-2023
Table 4: Europe biotechnology industry geography segmentation: $ million, 2023
Table 5: Europe biotechnology industry value forecast: $ million, 2023-28
Table 6: Novartis AG: key facts
Table 7: Novartis AG: Annual Financial Ratios
Table 8: Novartis AG: Key Employees
Table 9: Bayer AG: key facts
Table 10: Bayer AG: Annual Financial Ratios
Table 11: Bayer AG: Key Employees
Table 12: Bayer AG: Key Employees Continued
Table 13: AstraZeneca PLC: key facts
Table 14: AstraZeneca PLC: Annual Financial Ratios
Table 15: AstraZeneca PLC: Key Employees
Table 16: AstraZeneca PLC: Key Employees Continued
Table 17: BioNTech SE: key facts
Table 18: BioNTech SE: Annual Financial Ratios
Table 19: BioNTech SE: Key Employees
Table 20: Europe size of population (million), 2019-23
Table 21: Europe gdp (constant 2005 prices, $ billion), 2019-23
Table 22: Europe gdp (current prices, $ billion), 2019-23
Table 23: Europe inflation, 2019-23
Table 24: Europe consumer price index (absolute), 2019-23
Table 25: Europe exchange rate, 2019-23

List Of Figures

LIST OF FIGURES

Figure 1: Europe biotechnology industry value: $ million, 2018-23
Figure 2: Europe biotechnology industry category segmentation: $ million, 2018-2023
Figure 3: Europe biotechnology industry geography segmentation: % share, by value, 2023
Figure 4: Europe biotechnology industry value forecast: $ million, 2023-28
Figure 5: Forces driving competition in the biotechnology industry in Europe, 2023
Figure 6: Drivers of buyer power in the biotechnology industry in Europe, 2023
Figure 7: Drivers of supplier power in the biotechnology industry in Europe, 2023
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Europe, 2023
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Europe, 2023
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Europe, 2023